CMEMEDIUM SIGNALFINANCIAL10-K

CME Group shows robust growth with net income up 15.5% and operating cash flow up 15.9%, while balance sheet expansion reflects increased clearing and settlement activity.

The strong financial performance indicates CME is benefiting from higher trading volumes and volatility, driving both revenue growth and operational efficiency. The synchronized growth in assets, liabilities, and cash flows suggests healthy business expansion rather than financial stress.

Comparing 2026-02-26 vs 2025-02-27View on EDGAR →
FINANCIAL ANALYSIS

CME Group delivered strong across-the-board growth with net income rising 15.5% to $4.1B and operating cash flow increasing 15.9% to $4.3B, demonstrating robust operational performance. The dramatic expansion in current assets (+60.5%) and current liabilities (+56.7%) primarily reflects CME's role as a central counterparty, where increased trading activity drives proportional growth in clearing deposits and related obligations. The 52.7% increase in cash and equivalents to $4.4B, combined with strong profitability metrics, signals a financially healthy exchange operator capitalizing on market volatility and trading volume growth.

FINANCIAL STATEMENT CHANGES
Current Assets
Balance Sheet
+60.5%
$103.0B$165.4B

Current assets grew 60.5% — improving short-term liquidity or inventory/receivables build.

Current Liabilities
Balance Sheet
+56.7%
$102.3B$160.3B

Current liabilities surged 56.7% — significant near-term obligations; verify ability to meet short-term debt.

Total Liabilities
Balance Sheet
+52.9%
$111.0B$169.7B

Liabilities grew 52.9% — significant increase in debt or obligations, assess impact on financial flexibility.

Cash & Equivalents
Balance Sheet
+52.7%
$2.9B$4.4B

Cash position surged 52.7% — strong cash generation or capital raise providing significant financial cushion.

Total Assets
Balance Sheet
+44.4%
$137.4B$198.4B

Asset base grew 44.4% — expansion through organic growth, acquisitions, or capital deployment.

Operating Cash Flow
Cash Flow
+15.9%
$3.7B$4.3B

Operating cash flow grew 15.9% — strong conversion of earnings to cash, healthy business fundamentals.

Net Income
P&L
+15.5%
$3.5B$4.1B

Net income grew 15.5% — bottom-line growth signals improving overall business health.

Accounts Receivable
Balance Sheet
+11.5%
$573.1M$639.2M

Receivables grew 11.5% — monitor days sales outstanding for collection efficiency.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-27
ADDED
All references to "options" or "options contracts" in the text of this document refer to options on futures contracts.
Information about Contract Volume and Average Rate per Contract Unless otherwise noted, all amounts regarding contract volume and average rate per contract are for CME Group's listed futures and options on futures contracts and exclude CME Group's event contracts.
You should carefully read this entire Annual Report on Form 10-K, including Part II.
Management s Discussion and Analysis of Financial Condition and Results of Operations and the consolidated financial statements and the related notes.
Except as required by the federal securities laws, we undertake no obligation to update any forward-looking statement, release publicly any revisions to any forward-looking statements or report the occurrence of unanticipated events, whether as a result of new information, future events or otherwise.
+7 more — sign up free →
REMOVED
Information about Contract Volume and Average Rate per Contract All amounts regarding contract volume and average rate per contract are for CME Group's listed futures and options on futures contracts unless otherwise noted.
We undertake no obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise.
GENERAL DEVELOPMENT OF BUSINESS CME was founded in 1898 as a not-for-profit corporation.
It established its clearing house in 1919, which is operated as part of CME.
CME demutualized in 2000, and in 2002 its parent company, CME Group, completed an initial public offering of its Class A common stock (Nasdaq: CME).
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →